908 Devices Inc. (MASS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US65443P1021
908 Devices Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 56.20 m USD |
| Gross profit | 28.42 m USD |
| Operating income | -39.42 m USD |
| EBIT | 19.42 m USD |
| Net income | 19.49 m USD |
| Diluted EPS – continuing operations | 0.54 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About 908 Devices Inc.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
More stocks
- AEM (AEM.AT)
- Melcor Developments Ltd. (MRD.TO)
- Zhejiang Wufangzhai Industry Co. Ltd. A (603237.SS)
- Kedge Construction Co Ltd (2546.TW)
- Kinko Optical Co Ltd (6209.TW)
- LX Holdings Corp (383800.KS)
- TSEC Corp (6443.TW)
- Advantage Solutions Inc. (ADV)
- Yulon Finance Corp. Pfd. (9941A.TW)
- Fullink Technology Co. LTD. (301067.SZ)
- Groupe Guillin SA (ALGIL.PA)
- Lyell Immunopharma, Inc. (LYEL)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.